| http://dbpedia.org/ontology/abstract
|
Un sérétide est une association fixe d'un … Un sérétide est une association fixe d'un beta-2 agoniste à longue durée d'action, le Xinafoate de Salmétérol, et d'un gluco-corticoïde, le Propionate de Fluticasone. Le produit est présenté sous trois dosages et deux formes galéniques. Inhalateur de poudre dosé à 100, 250, et 500 micro grammes de Fluticasone avec toujours 50 micro grammes de Salmétérol. Posologie habituelle une inhalation matin et soir. Aérosol doseur avec 50, 125, 250 micro grammes de Fluticasone et toujours 25 micro grammes de Salmétérol. Posologie habituelle deux inhalations matin et soir. Produit et commercialisé par le laboratoire Glaxo Smith Kline.lisé par le laboratoire Glaxo Smith Kline.
, 플루티카손/살메테롤(Fluticasone/salmeterol)은 프로파노산 … 플루티카손/살메테롤(Fluticasone/salmeterol)은 프로파노산 플루티카손과 살메테롤을 가지고 만든 물질이며 천식, 만성 폐쇄성 폐질환 (COPD)을 관리하는 데 이용된다. 글락소스미스클라인이 애드베어(Advair / 미국 및 캐나다), 세레타이드(Seretide / 유럽, 오스트레일리아, 뉴질랜드), 비아니 (Viani, 독일), 애도에어(Adoair, 일본), 포에어(ForAir, 인도)와 같은 다양한 제품 이름으로 출시하여 놓았다. 대한민국에서는 세레타이드라는 이름으로 잘 알려져 있다. 전 세계 한 해 판매량은 2009년 기준으로 70억 달러에 육박한다. 미국 특허는 2010년에 만기되고 유럽 특허는 2013년에 만기된다. 한국산도스가 2014년 5월 14일 에어플루잘 포스피로(AirFluSal Fospiro)라는 이름으로 출시했다 에어플루잘 포스피로(AirFluSal Fospiro)라는 이름으로 출시했다
, サルメテロール・フルチカゾン（Salmeterol/Fluticasone）は、気管 … サルメテロール・フルチカゾン（Salmeterol/Fluticasone）は、気管支喘息や慢性閉塞性肺疾患（COPD）の長期管理に用いられる配合剤。日本での承認上の正式な一般名はサルメテロールキシナホ酸塩･フルチカゾンプロピオン酸エステル。 グラクソ・スミスクライン（GSK）が同社の長時間作用性β2刺激薬キシナホ酸サルメテロール（商品名セレベント）と吸入ステロイド喘息治療剤プロピオン酸フルチカゾン（商品名フルタイド）を配合し、同時に吸入できるようにした合剤で、GSKが日本で商品名アドエア(Adoair)、アメリカでアドヴェアー(Advair)で、ドイツ以外のEU諸国でセレタイド(Seretide)、ドイツでヴィアーニ(Viani)、またシュバルツファーマがドイツでアトマディスク(Atmadisc)の商品名で販売している。いずれも容器は紫色。イツでアトマディスク(Atmadisc)の商品名で販売している。いずれも容器は紫色。
, Fluticasone/salmeterol, sold under the bra … Fluticasone/salmeterol, sold under the brand name Advair among others, is a fixed-dose combination medication containing fluticasone propionate and salmeterol. It is used in the management of asthma and chronic obstructive pulmonary disease (COPD). It is used by inhaling the medication into the lungs. Common side effects include thrush, headache, and cough. Serious side effects may include worsening asthma, anaphylaxis, seizures, and heart problems. Safety in pregnancy and breastfeeding is unclear. Fluticasone, a corticosteroid, works by decreasing inflammation while salmeterol, a long-acting beta-adrenoceptor agonist (LABA), works by activating beta-2 adrenergic receptors. The combination was approved for medical use in the United States in 2000. A generic version was approved in the United States in 2019. In 2020, it was the 56th most commonly prescribed medication in the United States, with more than 11 million prescriptions., with more than 11 million prescriptions.
|
| http://dbpedia.org/ontology/alternativeName
|
Advair, Seretide, Cyplos, others
|
| http://dbpedia.org/ontology/casNumber
|
136112-01-1
|
| http://dbpedia.org/ontology/kegg
|
D08699
|
| http://dbpedia.org/ontology/medlinePlus
|
a699063
|
| http://dbpedia.org/ontology/pubchem
|
9811567
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Fluticasone_propionate_and_salmeterol.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://druginfo.nlm.nih.gov/drugportal/rn/136112-01-1 +
, https://druginfo.nlm.nih.gov/drugportal/name/fluticasone%20propionate%20mixture%20with%20salmeterol%20xinafoate +
|
| http://dbpedia.org/ontology/wikiPageID
|
846109
|
| http://dbpedia.org/ontology/wikiPageLength
|
11549
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1120849011
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Asthma +
, http://dbpedia.org/resource/Chronic_obstructive_pulmonary_disease +
, http://dbpedia.org/resource/Generic_drug +
, http://dbpedia.org/resource/Category:GSK_plc_brands +
, http://dbpedia.org/resource/Beta-adrenergic +
, http://dbpedia.org/resource/Beta-2_adrenergic_receptor +
, http://dbpedia.org/resource/Glucocorticoid +
, http://dbpedia.org/resource/Salmeterol +
, http://dbpedia.org/resource/Category:Antiasthmatic_drugs +
, http://dbpedia.org/resource/Macrophage +
, http://dbpedia.org/resource/Category:Wikipedia_medicine_articles_ready_to_translate +
, http://dbpedia.org/resource/Neutrophil +
, http://dbpedia.org/resource/European_Medicines_Agency +
, http://dbpedia.org/resource/Hypothalamic%E2%80%93pituitary%E2%80%93adrenal_axis +
, http://dbpedia.org/resource/Long-acting_beta-adrenoceptor_agonist +
, http://dbpedia.org/resource/Adenyl_cyclase +
, http://dbpedia.org/resource/Cyclic_AMP +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Corticosteroid +
, http://dbpedia.org/resource/Mast_cell +
, http://dbpedia.org/resource/Lymphocyte +
, http://dbpedia.org/resource/Basophil +
, http://dbpedia.org/resource/Mylan +
, http://dbpedia.org/resource/Anaphylaxis +
, http://dbpedia.org/resource/Oral_candidiasis +
, http://dbpedia.org/resource/Anti-inflammatory +
, http://dbpedia.org/resource/Fluticasone_propionate +
, http://dbpedia.org/resource/Catalyst +
, http://dbpedia.org/resource/Category:Combination_drugs +
, http://dbpedia.org/resource/Seizure +
, http://dbpedia.org/resource/Fixed-dose_combination +
, http://dbpedia.org/resource/Eosinophil +
, http://dbpedia.org/resource/Committee_for_Medicinal_Products_for_Human_Use +
|
| http://dbpedia.org/property/atcPrefix
|
R03
|
| http://dbpedia.org/property/atcSuffix
|
AK06
|
| http://dbpedia.org/property/caption
|
and salmeterol
, Fluticasone propionate
|
| http://dbpedia.org/property/casNumber
|
136112
|
| http://dbpedia.org/property/chemspiderid
|
7987322
|
| http://dbpedia.org/property/class
|
http://dbpedia.org/resource/Glucocorticoid +
, http://dbpedia.org/resource/Long-acting_beta-adrenoceptor_agonist +
|
| http://dbpedia.org/property/component
|
Fluticasone propionate
, Salmeterol
|
| http://dbpedia.org/property/kegg
|
D08699
|
| http://dbpedia.org/property/legalAu
|
S4
|
| http://dbpedia.org/property/legalCa
|
Rx-only
|
| http://dbpedia.org/property/legalEu
|
Rx-only
|
| http://dbpedia.org/property/legalStatus
|
Rx-only
|
| http://dbpedia.org/property/legalUk
|
POM
|
| http://dbpedia.org/property/legalUs
|
Rx-only
|
| http://dbpedia.org/property/medlineplus
|
a699063
|
| http://dbpedia.org/property/pregnancyAu
|
B3
|
| http://dbpedia.org/property/pubchem
|
9811567
|
| http://dbpedia.org/property/routesOfAdministration
|
Inhalation
|
| http://dbpedia.org/property/tradename
|
Advair, Seretide, Cyplos, others
|
| http://dbpedia.org/property/type
|
combo
|
| http://dbpedia.org/property/verifiedrevid
|
447411501
|
| http://dbpedia.org/property/width
|
225
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Asthma_and_copd_rx +
, http://dbpedia.org/resource/Template:Nbsp +
, http://dbpedia.org/resource/Template:Cite_web +
, http://dbpedia.org/resource/Template:Drugs.com +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Portal_bar +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:GlaxoSmithKline +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Wikipedia_medicine_articles_ready_to_translate +
, http://dbpedia.org/resource/Category:Combination_drugs +
, http://dbpedia.org/resource/Category:GSK_plc_brands +
, http://dbpedia.org/resource/Category:Antiasthmatic_drugs +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Formulation +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Fluticasone/salmeterol?oldid=1120849011&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Fluticasone_propionate_and_salmeterol.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Fluticasone/salmeterol +
|
| owl:sameAs |
http://dbpedia.org/resource/Fluticasone/salmeterol +
, http://sr.dbpedia.org/resource/Flutikazon/salmeterol +
, https://global.dbpedia.org/id/4mmcp +
, http://azb.dbpedia.org/resource/%D9%81%D9%84%D9%88%D8%AA%D9%8A%D9%83%D8%A7%D8%B3%D9%88%D9%86_%D8%A8%D8%B1%D9%88%D8%A8%D9%8A%D9%88%D9%86%D8%A7%D8%AA_/_%D8%B3%D8%A7%D9%84%D9%85%D9%8A%D8%AA%D9%8A%D8%B1%D9%88%D9%84 +
, http://bar.dbpedia.org/resource/Fluticason/Salmeterol +
, http://sh.dbpedia.org/resource/Flutikazon/salmeterol +
, http://ja.dbpedia.org/resource/%E3%82%B5%E3%83%AB%E3%83%A1%E3%83%86%E3%83%AD%E3%83%BC%E3%83%AB%E3%83%BB%E3%83%95%E3%83%AB%E3%83%81%E3%82%AB%E3%82%BE%E3%83%B3 +
, http://or.dbpedia.org/resource/%E0%AC%AB%E0%AD%8D%E0%AC%B2%E0%AD%81%E0%AC%9F%E0%AC%BF%E0%AC%95%E0%AC%BE%E0%AC%B8%E0%AD%8B%E0%AC%A8/%E0%AC%B8%E0%AC%BE%E0%AC%B2%E0%AC%AE%E0%AD%87%E0%AC%9F%E0%AD%87%E0%AC%B0%E0%AD%8B%E0%AC%B2 +
, http://www.wikidata.org/entity/Q581334 +
, http://fr.dbpedia.org/resource/S%C3%A9r%C3%A9tide +
, http://vi.dbpedia.org/resource/Fluticasone/salmeterol +
, http://ko.dbpedia.org/resource/%ED%94%8C%EB%A3%A8%ED%8B%B0%EC%B9%B4%EC%86%90/%EC%82%B4%EB%A9%94%ED%85%8C%EB%A1%A4 +
, http://rdf.freebase.com/ns/m.03gl20 +
|
| rdf:type |
http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/ontology/CombinationDrug +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Drug103247620 +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Name106333653 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/class/yago/LanguageUnit106284225 +
, http://dbpedia.org/class/yago/WikicatAntiasthmaticDrugs +
, http://dbpedia.org/class/yago/TradeName106845599 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/WikicatGlaxoSmithKlineBrands +
, http://dbpedia.org/class/yago/Substance100020090 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/WikicatCombinationDrugs +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
플루티카손/살메테롤(Fluticasone/salmeterol)은 프로파노산 … 플루티카손/살메테롤(Fluticasone/salmeterol)은 프로파노산 플루티카손과 살메테롤을 가지고 만든 물질이며 천식, 만성 폐쇄성 폐질환 (COPD)을 관리하는 데 이용된다. 글락소스미스클라인이 애드베어(Advair / 미국 및 캐나다), 세레타이드(Seretide / 유럽, 오스트레일리아, 뉴질랜드), 비아니 (Viani, 독일), 애도에어(Adoair, 일본), 포에어(ForAir, 인도)와 같은 다양한 제품 이름으로 출시하여 놓았다. 대한민국에서는 세레타이드라는 이름으로 잘 알려져 있다. 전 세계 한 해 판매량은 2009년 기준으로 70억 달러에 육박한다. 미국 특허는 2010년에 만기되고 유럽 특허는 2013년에 만기된다. 한국산도스가 2014년 5월 14일 에어플루잘 포스피로(AirFluSal Fospiro)라는 이름으로 출시했다 에어플루잘 포스피로(AirFluSal Fospiro)라는 이름으로 출시했다
, Un sérétide est une association fixe d'un … Un sérétide est une association fixe d'un beta-2 agoniste à longue durée d'action, le Xinafoate de Salmétérol, et d'un gluco-corticoïde, le Propionate de Fluticasone. Le produit est présenté sous trois dosages et deux formes galéniques. Inhalateur de poudre dosé à 100, 250, et 500 micro grammes de Fluticasone avec toujours 50 micro grammes de Salmétérol. Posologie habituelle une inhalation matin et soir. Aérosol doseur avec 50, 125, 250 micro grammes de Fluticasone et toujours 25 micro grammes de Salmétérol. Posologie habituelle deux inhalations matin et soir.habituelle deux inhalations matin et soir.
, Fluticasone/salmeterol, sold under the bra … Fluticasone/salmeterol, sold under the brand name Advair among others, is a fixed-dose combination medication containing fluticasone propionate and salmeterol. It is used in the management of asthma and chronic obstructive pulmonary disease (COPD). It is used by inhaling the medication into the lungs. The combination was approved for medical use in the United States in 2000. A generic version was approved in the United States in 2019. In 2020, it was the 56th most commonly prescribed medication in the United States, with more than 11 million prescriptions., with more than 11 million prescriptions.
, サルメテロール・フルチカゾン（Salmeterol/Fluticasone）は、気管 … サルメテロール・フルチカゾン（Salmeterol/Fluticasone）は、気管支喘息や慢性閉塞性肺疾患（COPD）の長期管理に用いられる配合剤。日本での承認上の正式な一般名はサルメテロールキシナホ酸塩･フルチカゾンプロピオン酸エステル。 グラクソ・スミスクライン（GSK）が同社の長時間作用性β2刺激薬キシナホ酸サルメテロール（商品名セレベント）と吸入ステロイド喘息治療剤プロピオン酸フルチカゾン（商品名フルタイド）を配合し、同時に吸入できるようにした合剤で、GSKが日本で商品名アドエア(Adoair)、アメリカでアドヴェアー(Advair)で、ドイツ以外のEU諸国でセレタイド(Seretide)、ドイツでヴィアーニ(Viani)、またシュバルツファーマがドイツでアトマディスク(Atmadisc)の商品名で販売している。いずれも容器は紫色。イツでアトマディスク(Atmadisc)の商品名で販売している。いずれも容器は紫色。
|
| rdfs:label |
サルメテロール・フルチカゾン
, 플루티카손/살메테롤
, Fluticasone/salmeterol
, Sérétide
|
